Glutamate receptors, including AMPA and NMDA subtypes, are pivotal mediators of excitatory transmission and plasticity across the mammalian central nervous system. Their regulation, which involves ...
Surprising findings published in PNAS have implications for understanding and treating neurological and neuropsychiatric disorders.
When it comes to brain proteins, small changes can make a dramatic difference. Researchers studying NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment ...
Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...
Northwestern University researchers have identified structural features in engineered cell receptors that correlate with ...
The FDA approved combination dextromethorphan and bupropion extended-release tablets (Auvelity) for adults with major depressive disorder (MDD), Axsome Therapeutics announced on Friday.
Please provide your email address to receive an email when new articles are posted on . Cognitive recovery was greatest within the first 6 months of diagnosis, persisting up to 36 months. After the 36 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback